​

Adverum Bio (ADVM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Adverum Bio Revenue Highlights

Latest Revenue (Y)

$1.00M

0

Main Segment (Y)

Reportable Segment

Adverum Bio Revenue by Period

Adverum Bio Revenue by Year

DateRevenueChange
2024-12-31$1.00M-72.22%
2023-12-31$3.60M100.00%
2022-12-31--100.00%
2021-12-31$7.50M100.00%
2020-12-31--100.00%
2019-12-31$250.00K-84.49%
2018-12-31$1.61M-12.82%
2017-12-31$1.85M27.08%
2016-12-31$1.46M-37.26%
2015-12-31$2.32M305.42%
2014-12-31$572.00K19.17%
2013-12-31$480.00K1500.00%
2012-12-31$30.00K-

Adverum Bio generated $1.00M in revenue during NA 2024, up -72.22% compared to the previous quarter, and up 400.00% compared to the same period a year ago.

Adverum Bio Revenue by Quarter

DateRevenueChange
2024-12-31--100.00%
2024-09-30$1.00M100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$-3.60M100.00%
2023-09-30-100.00%
2023-06-30--100.00%
2023-03-31$3.60M100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31--100.00%
2021-12-31$-7.50M100.00%
2021-09-30-100.00%
2021-06-30--100.00%
2021-03-31$7.50M100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--100.00%
2019-12-31$-250.00K-200.00%
2019-09-30$250.00K100.00%
2019-06-30-100.00%
2019-03-31--100.00%
2018-12-31$70.00K-91.60%
2018-09-30$833.00K68.97%
2018-06-30$493.00K128.24%
2018-03-31$216.00K-53.15%
2017-12-31$461.00K-0.43%
2017-09-30$463.00K-
2017-06-30$463.00K0.22%
2017-03-31$462.00K-5.33%
2016-12-31$488.00K23.54%
2016-09-30$395.00K28.66%
2016-06-30$307.00K15.85%
2016-03-31$265.00K-72.40%
2015-12-31$960.00K0.73%
2015-09-30$953.00K369.46%
2015-06-30$203.00K-
2015-03-31$203.00K-
2014-12-31$203.00K-0.49%
2014-09-30$204.00K51.11%
2014-06-30$135.00K350.00%
2014-03-31$30.00K100.00%
2013-12-31--100.00%
2013-09-30$30.00K-80.00%
2013-06-30$150.00K-50.00%
2013-03-31$300.00K-

Adverum Bio generated - in revenue during Q4 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Adverum Bio Revenue Breakdown

Adverum Bio Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Reportable Segment$1.00M

Adverum Bio's latest annual revenue breakdown by segment (product or service), as of Dec 24: Reportable Segment (100.00%).

Adverum Bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
RYTMRhythm Pharmaceuticals$130.13M$41.83M
STOKStoke Therapeutics$36.55M$22.61M
MGTXMeiraGTx$33.28M-
QUREuniQure$27.12M$5.22M
ADAGAdagene$18.11M$833.34K
AFMDAffimed$8.28M$155.00K
ABSIAbsci$4.53M$665.00K
ADVMAdverum Bio$1.00M-
RZLTRezolute--
KODKodiak Sciences--
SLDBSolid Biosciences--
ANTXAN2 Therapeutics--
RCKTRocket Pharmaceuticals--
AVTEAerovate Therapeutics--
KZRKezar Life Sciences--
PASGPassage Bio--
ACRVAcrivon Therapeutics--
GLMDGalmed Pharmaceuticals--
MREOMereo BioPharma Group--

ADVM Revenue FAQ

What is Adverum Bio’s yearly revenue?

Adverum Bio's yearly revenue for 2024 was $1M, representing a decrease of -72.22% compared to 2023. The company's yearly revenue for 2023 was $3.6M, representing an increase of 100.00% compared to 2022. ADVM's yearly revenue for 2022 was $0, representing a decrease of -100.00% compared to 2021.

What is Adverum Bio’s quarterly revenue?

Adverum Bio's quarterly revenue for Q4 2024 was $0, a -100.00% decrease from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $1M, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). ADVM's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023).

What is Adverum Bio’s revenue growth rate?

Adverum Bio's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.

What are Adverum Bio’s revenue streams?

Adverum Bio's revenue streams in c 24 are Reportable Segment

What is Adverum Bio’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Adverum Bio was Reportable Segment. This segment made a revenue of $1M, representing 100.00% of the company's total revenue.